Zacks Research Forecasts Higher Earnings for ProAssurance

ProAssurance Co. (NYSE:PRA - Free Report) - Research analysts at Zacks Research boosted their Q3 2025 earnings estimates for shares of ProAssurance in a report released on Thursday, March 13th. Zacks Research analyst K. Dey now anticipates that the insurance provider will post earnings of $0.28 per share for the quarter, up from their prior estimate of $0.23. The consensus estimate for ProAssurance's current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance's Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.91 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.25 EPS, Q3 2026 earnings at $0.29 EPS, Q4 2026 earnings at $0.30 EPS, FY2026 earnings at $1.06 EPS and FY2027 earnings at $1.17 EPS.

ProAssurance (NYSE:PRA - Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The insurance provider reported $0.36 EPS for the quarter, beating the consensus estimate of $0.17 by $0.19. The company had revenue of $287.52 million for the quarter, compared to the consensus estimate of $274.56 million. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%.

Separately, StockNews.com upgraded shares of ProAssurance from a "hold" rating to a "buy" rating in a research note on Thursday, March 6th.

Remove Ads

ProAssurance Stock Performance

Shares of NYSE:PRA traded up $7.53 during trading on Monday, hitting $23.07. The company's stock had a trading volume of 14,036,712 shares, compared to its average volume of 310,795. The company has a 50-day moving average of $15.07 and a 200-day moving average of $15.27. ProAssurance has a 12 month low of $10.76 and a 12 month high of $23.51. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 27.80 and a beta of 0.21.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Wealthfront Advisers LLC purchased a new position in ProAssurance during the fourth quarter worth $359,000. Barclays PLC raised its holdings in shares of ProAssurance by 307.5% in the third quarter. Barclays PLC now owns 85,117 shares of the insurance provider's stock valued at $1,280,000 after acquiring an additional 64,228 shares in the last quarter. State Street Corp raised its holdings in ProAssurance by 1.8% in the third quarter. State Street Corp now owns 1,968,754 shares of the insurance provider's stock worth $29,610,000 after purchasing an additional 34,247 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in ProAssurance by 34.8% in the third quarter. JPMorgan Chase & Co. now owns 253,175 shares of the insurance provider's stock worth $3,808,000 after purchasing an additional 65,325 shares in the last quarter. Finally, FMR LLC grew its stake in shares of ProAssurance by 197.8% during the third quarter. FMR LLC now owns 12,063 shares of the insurance provider's stock worth $181,000 after acquiring an additional 8,012 shares during the last quarter. 85.58% of the stock is owned by hedge funds and other institutional investors.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.